However, when SKOV3 and HEY cells were treated with carboplatin (40 μg/mL) or paclitaxel (10 ng/mL), RFP knockdown significantly inhibited cancer cell proliferation (Fig. 3B). This evidence concerns the gene TRIM27 and cancer.